A breakthrough procedure is helping patients when it comes to total ankle replacement surgery. Mercy Medical Center in ...

A clinical study led by Lew C. Schon, MD, FACS, FAAOS, Director of Orthopedic Innovation at The Institute of Foot and Ankle ...

The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the United States over the ...

Zimmer Biomet offers a range of orthopaedic implants and robotic technologies for joint replacement. Areas of the body within the portfolio include knee, hip, shoulder, and ankle indications, amongst ...

The deal will give Zimmer Biomet access to Paragon's surgical implants and equipment used to treat foot and ankle ailments, while bolstering its fracture and trauma, and joint replacement businesses.

Zimmer Biomet has secured the US Food and Drug Administration (FDA) 510(k) clearance for its total knee implant component, Persona SoluTion porous plasma spray (PPS) femur. It provides an ...

to limit the body’s contact with metals such as nickel, cobalt and chromium. Zimmer Biomet said it would commercially launch the femur implant in the first quarter of next year. In late November ...

The approval comes after an Investigational Device Exemption (IDE) study and non-clinical testing demonstrated the safety and effectiveness of the implant. According to Zimmer Biomet, the Oxford ...

WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket ...

Zimmer Biomet has hired The Terminator to tell the world that “if you rest, you rust.” The manufacturer of orthopedic medtech products is getting its message about how to increase mobility and ...

Zimmer Biomet adjusted its 2024 adjusted EPS outlook from $8.00-$8.15 to $7.95-$8.05 compared to the consensus of $7.95. The company expects 2024 revenue growth of 3.5%-4% versus the prior ...